A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency

Journal of Virology

Volumn 73, Issue 7, 1999, Pages 5663-5670

  Prichard, Mark N ^a,c   Gao, Ning ^a,d   Jairath, Sanju ^a   Mulamba, Gilbert ^b   Krosky, Paula ^b   Coen, Donald M ^b   Parker, Breck O ^a,e   Pari, Gregory S ^a,f  

^a HYBRIDON INC   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Entelos Inc   (United States)

^d ASTRAZENECA   (United Kingdom)

^e Schleicher and Schuell Inc   (United States)

^f UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE;

ARTICLE; GENE DELETION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; PRIORITY JOURNAL; VIRUS GENE; VIRUS ISOLATION; VIRUS REPLICATION;

EID: 0033033631     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.7.5663-5670.1999     Document Type: Article

References (49)

1. Baldanti, F., E. Silini, A. Sarasini, C. L. Talarico, S. C. Stanat, K. K. Biron, M. Furione, F. Bono, G. Palu, and G. Gerna. 1995. A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J. Virol. 69:796-800.
2. Chee, M. S., A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, R. Cerny, T. Horsnell, C. A. I. Hutchison, T. Kouzarides, J. A. Martignetti, E. Preddie, S. C. Satchwell, P. Tomlinson, K. M. Weston, and B. G. Barrell. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125-170.
3. Chee, M. S., G. L. Lawrence, and B. G. Barrell. 1989. Alpha-, beta- and gammaherpesviruses encode a putative phosphotransferase. J. Gen. Virol. 70:1151-1160.
4. Cheng, Y.-C., S. P. Grill, G. E. Dutschman, K. B. Frank, J.-F. Chiou, K. F. Bastow, and K. Nakayama. 1984. Effects of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new antiherpesvirus compound, on synthesis of macromolecules in herpes simplex virus-infected cells. Antimicrob. Agents Chemother. 26:283-288.
5. Cheng, Y.-C., E.-S. Huang, J.-C. Lin, E.-C. Mar, J. S. Pagano, G. E. Dutschman, and S. P. Grill. 1983. Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc. Natl. Acad. Sci. USA 80:2767-2770.
6. Chou, S., A. Erice, M. C. Jordan, G. M. Vercellotti, K. R. Michels, C. L. Talarico, S. C. Stanat, and K. K. Biron. 1995. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J. Infect. Dis. 171:576-583.
7. Chou, S., S. Guentzel, K. R. Michels, R. C. Miner, and W. L. Drew. 1995. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J. Infect. Dis. 172:239-242.
8. Chou, S., G. Marousek, S. Guentzel, S. E. Follansbee, M. E. Poscher, J. P. Lalezari, R. C. Miner, and W. L. Drew. 1997. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. J. Infect. Dis. 176:786-789.
9. Coen, D. M., A. F. Irmiere, J. G. Jacobson, and K. M. Kerns. 1989. Low levels of herpes simplex virus thymidine-thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model. Virology 168:221-231.
10. Collaborative DHPG Treatment Study Group. 1986. Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies. N. Engl. J. Med. 314:801-805.
11. Compton, T. 1993. An immortalized human fibroblast cell line is permissive for human cytomegalovirus infection. J. Virol. 67:3644-3648.
12. Daris, M., and W. Miller. 1998. Personal communication.
13. Drew, W. L., D. Ives, J. P. Lalezari, C. Crumpacker, S. E. Follansbee, S. A. Spector, C. A. Benson, D. N. Friedberg, L. Hubbard, M. J. Stempien, et al. 1995. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group. N. Engl. J. Med. 333:615-620.
14. Fleckenstein, B., I. Muller, and J. Collins. 1982. Cloning of the complete human cytomegalovirus genome in cosmids. Gene 18:39-46.
15. Gibson, U., C. Heid, and P. Williams. 1996. A novel method for real time quantitative RT-PCR. Genome Res. 6:995-1001.
16. Greaves, R. F., J. M. Brown, J. Vieira, and E. S. Mocarski. 1995. Insertion and deletion mutagenesis of the US3 and IRS1 regulatory genes of human cytomegalovirus using the selectable marker guanosine phosphoribosyl transferase (gpt). J. Gen. Virol. 76:2151-2160.
17. Greaves, R. F., J. M. Brown, J. Vieira, and E. S. Mocarski. 1995. Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene. J. Gen. Virol. 76:2151-2160.
18. Halbert, C., W. Demers, and D. Galloway. 1991. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65:473-478.
19. Hanson, M. N., L. C. Preheim, S. Chou, C. L. Talarico, K. K. Biron, and A. Erice. 1995. Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir. Antimicrob. Agents Chemother. 39:1204-1205.
20. He, Z., and D. Coen. 1996. Unpublished data.
21. He, Z., Y. S. He, Y. Kim, L. Chu, C. Ohmstede, K. K. Biron, and D. M. Coen. 1997. The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. J. Virol. 71:405-411.
22. Held, C., J. Stevens, K. Livak, and P. Williams. 1996. Real time quantitative PCR. Genome Res. 6:986-994.
23. Jacobson, M. A. 1997. Cytomegalovirus retinitis: new developments in prophylaxis and therapy. AIDS Clin. Rev. 1997:249-269.
24. Jones, T. 1998. Personal communication.
25. Jones, T. 1997. Personal communication.
26. Katlama, C. 1997. Management of CMV retinitis in HIV infected patients. Genitourin. Med. 73:169-173.
27. Leach, F. S., and E. S. Mocarski. 1989. Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression. J. Virol. 63:1783-1791.
28. Littler, E., A. Stuart, and M. Chee. 1992. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 358:160-162.
29. Lurain, N., L. Spafford, and K. Thompson. 1994. Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir. J. Virol. 68:4427-4431.
30. Michel, D., I. Pavic, A. Zimmermann, E. Haupt, K. Wunderlich, M. Heuschmid, and T. Mertens. 1996. The UL97 gene product of human cytomegalovirus is an early-late protein with a nuclear localization but is not a nucleoside kinase. J. Virol. 70:6340-6346.
31. Mocarski, E. S., G. W. Kemble, J. M. Lyle, and R. F. Greaves. 1996. A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation. Proc. Natl. Acad. Sci. USA 93:11321-11326.
32. Morgenstern, J., and H. Land. 1990. Advanced mammalian gene transfer: high-titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
33. Ng, T. I., C. Talarico, T. C. Burnette, K. Biron, and B. Roizman. 1996. Partial substitution of the functions of the herpes simplex virus 1 U(L)13 gene by the human cytomegalovirus U(L)97 gene. Virology 225:347-358.
34. Prichard, M. N., G. M. Duke, and E. S. Mocarski. 1996. Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replication. J. Virol. 70:3018-3025.
35. Prichard, M. N., N. Gao, G. Duke, E. S. Mocarski, D. Yu, S. Jairath, and G. Pari. Human cytomegalovirus uracil DNA glycosylase participates in the origin specific initiation of viral DNA synthesis and is associated with ppUL44. Submitted for publication.
36. Prichard, M. N., N. Gao, S. Jairath, B. Parker, and G. Pari. 1997. Unpublished data.
37. Prichard, M. N., S. R. Turk, L. A. Coleman, S. L. Engelhardt, C. Shipman, Jr., and J. C. Drach. 1990. A microtiter virus yield reduction assay for the evaluation of antiviral compounds against human cytomegalovirus and herpes simplex virus type 1. J. Virol. Methods 28:101-106.
38. Smith, I. L., J. M. Cherrington, R. E. Jiles, M. D. Fuller, W. R. Freeman, and S. A. Spector. 1997. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. J. Infect. Dis. 176:69-77.
39. Spaete, R. R., and E. S. Mocarski. 1985. Regulation of cytomegalovirus gene expression: α and β promoters are trans activated by viral functions in permissive human fibroblasts. J. Virol. 56:135-143.
40. Studies of Ocular Complications of AIDS Research Group and AIDS Clinical Trials Group. 1997. Foscarnet-ganciclovir cytomegalovirus retinitis trial. 5. Clinical features of cytomegalovirus retinitis at diagnosis. Am. J. Ophthalmol. 124:141-157.
41. Studies of Ocular Complications of AIDS Research Group and AIDS Clinical Trials Group. 1997. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Ann. Intern. Med. 126:264-274.
42. Sullivan, V., K. K. Biron, C. Talarico, S. C. Stanat, M. D. Davis, L. M. Pozzi, and D. M. Coen. 1993. A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivitives. Antimicrob. Agents Chemother. 37:19-25.
43. Sullivan, V., and D. Coen. 1992. Unpublished data.
44. Sullivan, V., C. L. Talarico, S. C. Stanat, M. Davis, D. M. Coen, and K. K. Biron. 1992. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 359:85.
45. Talarico, C., S. Smith, T. Burnette, W. Miller, M. Davis, S. Stanat, Z. He, T. Ng, D. Coen, B. Roizman, and K. Biron. 1998. Unpublished data.
46. van Zeijl, M., J. Fairhurst, E. Z. Baum, L. Sun, and T. R. Jones. 1997. The human cytomegalovirus UL97 protein is phosphorylated and a component of virions. Virology 231:72-80.
47. Vieira, J., H. E. Farrell, W. D. Rawlinson, and E. S. Mocarski. 1994. Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette. J. Virol. 68:4837-4846.
48. Wing, B. A., and E. S. Huang. 1995. Analysis and mapping of a family of 3′-coterminal transcripts containing coding sequences for human cytomegalovirus open reading frames UL93 through UL99. J. Virol. 69:1521-1531.
49. Wolf, D. G., I. L. Smith, D. J. Lee, W. R. Freeman, M. Flores-Aguilar, and S. A. Spector. 1995. Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma. J. Clin. Investig. 95:257-263.